Jeffrey Lowell

Appearances

PHARMACOLOGIC ANTICOAGULATION IS PROTECTIVE AGAINST RECURRENT VENOUS THROMBOEMBOLIC EVENTS ASSOCIATED WITH JANUS KINASE INHIBITOR USE IN PATIENTS WITH PRIOR THROMBOSIS
Date
May 20, 2024
Janus Kinase inhibitors (JAKi) tofacitinib and upadacitinib are emerging inflammatory bowel disease and rheumatology therapies…
Presenter
Jeffrey Lowell
Speakers
Garvita Sharma
Arun Swaminath
Keith Sultan